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The word "pathogen" often brings to mind morose images and other words such as 
"illness," "malaria," and "outbreak": words associated with animal pathogens, in 
pa11icular, the ones that make us humans sick. However, some pathogens also affect 
another major kingdom, plants, and one of the more devastating pathogens to the plant 
kingdom is the bacteria Agrobacterium tumefaciens. This organism has a Type IV 
Secretion System that allows it to transfer a piece oft-DNA into the host cell; this DNA 
integrates into the eukaryotic genome and establishes infection by utilizing the host's 
transcription machinery. This unique and effective means of infection has been utilized 
industrially to generate numerous transgenic crops. 
A. tumefaciens is the causal agent of crown gall disease, an affliction in which the
transformed t-DNA drastically alters hormone levels near the site of infection. Localized 
cell proliferation occurs and this ultimately results in a massive tumor-like structure in 
the plant, known as a "crown gall." 
A. tumefaciens has been heretofore thought a strict plant pathogen. However, several
strains of A. tumefaciens have been isolated from human patients with compromised 
immune systems. Several studies were undertaken to elicit the mechanism of infection in 
animals. For example, it has been demonstrated that the human isolates have the ability 
to invade mammalian cell lines in vitro. Our study compared the ability of the "human 
strains" to evade lysis by complement with that of the "plant strain." 
Complement is a non-specific immune defense used by the body to attack and destroy 
foreign pathogens, specifically bacteria. Vari.ous components play a role in opsonization, 
inflammation, or formation of a "membrane-attack complex" ( or MAC). While only 
gram-negative bacteria are susceptible to the MAC-forming ability of complement, both 
gram-negative and gram-positive bacteria alike can be opsonized, or directed towards 
phagocytic immune cells, by complement factors. The MAC is a means to create pores 
in the bacterial cell membrane, thereby disrupting the structural integrity of the 
membrane, resulting in cell death. Figure 1 shows a representation of the chain of events 
in complement-mediated immunity. 
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Figure 1: Complement componenets interact to attack and kill pathogens through 
various mechanisms. Gram-negative bacteria, such as £. coli, are susceptible to the 
MAC-forming ability of the component system. This study investigated the ability of 
certain strains of A. tumefaciens to resist lysis by complement, mediated by the MAC. 
The ability to resist complement-mediated lysis in A. tumefaciens is not entirely 
surprising; it has already been demonstrated that certain isolates of the closely-related 
Hrucella abortus do not activate the complement cascade in vitro. This study also found 
that the complement-resistant and complement-sensitive strains of B. abortus differ in the 
presence of 0-antigen on the bacterial cell surface. This suggests that 0-antigen masks a 
complement-activating site on the bacteria, and that only in the absence of 0-antigen can 
the classical complement pathway be activated. (Eisenschenk et al, 1999). This steric 
hindrance of complement components by the 0-polysaccharide is common among 
bacteria, and those with "rough" membranes (short or no 0-antigen) are known to be 
more sensitive. 
Other common mechanisms ofresistance to complement exhibited by certain 
microorganisms include production and secretion of bacterial products that somehow 
inactivate the complement components. For example, certain proteases cleave the 
complement proteins, rendering them useless. Similarly, other compounds can inactivate 
complement simply by binding to active sites on the components, effectively preventing 
them from doing their job. If the human isolates of A. tumefaciens exhibit increased 
resistance to complement, certain protein homologies can be searched for in the bacterial 
genome that might suggest products such as these being produced by the human strains of 
A. tumefaciens, and probably, for some reason, not by the plant strain.
In order to determine to what extent the animal strains are resistant to lysis by 
complement, three human strains (UCLA654, UCLA779, and UCLA802), one plant 
strain (C58), and E. coli (control) were used in a bactericidal assay. Strains were grown 
overnight in Luria broth to stationary phase and diluted to 3.3x105 cells/ml at t = -lhr. 
500µ1 guinea pig complement was boiled for l 0 minutes, effectively killing all 
complement components (heat-killed complement, or HKC). 150µ1 (~5xl04 cells) of 
each culture was incubated with 1 0µl (1 :20), 5µ1 (1 :40), and 2.5µ1 (1 :80) of both active 
guinea pig complement and HKC in a total volume of 200µ1 (LB) for a period of 10 
hours. Control samples contained 150µ1 bacteria and 50µ1 LB. Using a microtiter plate­
reader, absorbances were measured at 405nm for t=0, 1, 2, 3, 6, 8, and 10hr time points. 
Developing an assay that would allow for accurate evaluation of complement­
mediated killing in both E. coli and the plant and human strains of A. tumefaciens was the 
first obstacle in the progress of this endeavor. After adjusting several parameters (serum 
dilution, bacterial count, time, temperature .. . ) over numerous trial runs, the assay appears 
to make possible the monitoring of cell growth over a certain time period. 
Most recent experiments indicate that the human strains do exhibit increased 
resistance to complement-mediated lysis. Figures 2, 3, and 4 compare the growth of 
control, plant and human strains over 10 hours in three settings: 1) no complement, 
2) active complement, and 3) heat-killed complement. As seen in Figure 4, UCLA802, a
representative human strain of A. tumefaciens, samples with active complement (pink 
squares) do not exhibit total resistance, but at the same time, do not show complete death. 
This suggests that evasion of the complement system could in fact be a mechanism that 
allows these "human strains" to survive inside certain hosts, while other plant strains 
cannot do so. 
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Figure 2: Growth of control 
samples E. coli. The control
and HKC-containing cultures 
clearly exhibited better 
growth over IO hours than 
did the sample containing 
active complement. 
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Figure 3: Growth of plant 
strain CS8 in control, 
serum, and HKC samples. 
As expected, the bacteria 
containing HKC grew and 
those with active serum failed 
to do so. However, the 
control sample did not show 
growth over the 10-hr. 
< .... 0 ,-� -- ---serum - -
period, an error which in 
future studies can be 
remedied. 
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Figure 4: Representative 
graph comparing human 
strain growth in presence 
and absence of active 
complement. UCLA802
displayed intermediate 
resistance and further testing 
will hopefully confirm the 
hypothesis that human strains 
of A. tumefaciens are in fact
more resistant to complement 
than their plant-infecting 
sibling strain, CS8. 
In conclusion, an assay was developed that effectively allows monitoring of 
complement-mediated killing of bacteria over a 10-hr. period. This assay was used to 
determine the extent to which the human strains of Agrobacterium tumefaciens are 
resistant to this branch of the immune system. The results were not entirely conclusive, 
but it appears that the human strains (e.g. UCLA802, Fig. 4) are in fact more resistant 
than the plant strains. Further studies will be needed to confirm these preliminary results 
and, when con filmed, elicit the exact nature of complement resistance in this bacteria. 
Such mechanisms could include varying the O-antigen component of the bacterial cell 
membrane and secreted bacterial products that inactivate complement components, such 
as proteases and other known complement-inactivating proteins. 
